Blood thinner beats aspirin for heart attack prevention

A new study suggests clopidogrel, a blood thinner, is more effective than aspirin in preventing heart attacks and strokes. The research, involving nearly 29,000 patients with coronary artery disease, found clopidogrel superior without increasing major bleeding risk, challenging decades of aspirin recommendations. This discovery, presented at the European Society of Cardiology congress and published in The Lancet, could lead to widespread adoption of clopidogrel for treating coronary artery disease.